Skip to main content
. 2021 Mar 16;4(6):296–305. doi: 10.1093/jcag/gwab003

Table 2.

Model-based hospital, physician and prescription medication cost estimates of IBD per patient in Saskatchewan, Canada, from 1999/2000 to 2016/2017

Fiscal year Hospital Physician Prescription medication
1999/2000 4373 (3752–5098) 271 (251–291) 660 (595–732)
2000/2001 4849 (4223–5569) 280 (259–301) 670 (608–739)
2001/2002 4582 (4033–5205) 293 (273–314) 754 (685–830)
2002/2003 4388 (3722–5173) 281 (263–301) 1006 (893–1134)
2003/2004 4368 (3883–4913) 320 (300–341) 1122 (1003–1256)
2004/2005 4530 (3949–5196) 323 (304–343) 1256 (1125–1401)
2005/2006 4353 (3854–4916) 291 (273–309) 1350 (1208–1510)
2006/2007 4560 (4018–5175) 299 (283–316) 1527 (1383–1686)
2007/2008 4578 (3885–5394) 300 (283–318) 1749 (1583–1932)
2008/2009 4682 (3992–5491) 301 (284–319) 2227 (2020–2455)
2009/2010 3871 (3344–4481) 275 (260–290) 2604 (2369–2862)
2010/2011 5032 (4001–6327) 323 (306–340) 2918 (2659–3201)
2011/2012 5687 (4503–7180) 333 (316–351) 3416 (3119–3742)
2012/2013 4887 (4202–5685) 326 (309–343) 3987 (3647–4358)
2013/2014 4604 (3880–5464) 308 (295–323) 4831 (4427–5271)
2014/2015 4787 (4011–5713) 310 (297–325) 5443 (5011–5912)
2015/2016 3544 (3150–3987) 324 (310–339) 5951 (5475–6468)
2016/2017 4477 (3633–5517) 295 (273–319) 6530 (6024–7078)
Change (%)* 0.8 (−0.1 to 1.6) 0.7 (0.4–1.0) 15.4 (14.6–16.2)

Estimated costs of IBD presented in 2013/14 Canadian dollars with 95% confidence intervals.

IBD, inflammatory bowel disease.

*Average annual percentage change. Bolded statistically significant change over time.